Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial
Zamergrad, M. V., Parfenov, V. A., Agafina, A. S., Lyamina, N. V., Gavrik, M. M., Kuchumova, L. R., Barantsevich, E. R., Krasnov, V. S., Ivanova, A. A., Vladykin, A. L., Ishchenko, K. А.
Published in Nevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika (23.10.2023)
Published in Nevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika (23.10.2023)
Get full text
Journal Article